Humphrey, H. N. http://orcid.org/0000-0002-1238-9741
Diodato, A. http://orcid.org/0000-0002-6753-3085
Isner, J.-C. http://orcid.org/0000-0003-4504-4392
Walker, E. http://orcid.org/0000-0002-9407-8946
Lacy-Colson, J. http://orcid.org/0000-0002-5151-8358
Nedjai, B. http://orcid.org/0000-0001-8711-4577
Daniels, I. R. http://orcid.org/0000-0002-9114-0812
McDermott, F. D.
Walker, E. T.
Battersby, N. J.
Sisodia, H.
Rottenburg, H.
Cunningham, C.
Bird, S.
Jones, G. A. R.
Wise, D.
Spencer, S. J.
,
Funding for this research was provided by:
Origin Sciences Limited
Article History
Received: 9 August 2022
Accepted: 3 September 2022
First Online: 27 September 2022
Declarations
:
: Financial Interests ORI-EGI-02 Study Group: Author HN Humphrey is a surgical research fellow funded by an unrestricted research grant from Origin Sciences. Author A Diodato is employed by Origin Sciences. Author J-C Isner is employed by Origin Sciences. Author E Walker is employed by Origin Sciences. Author J Lacey-Coulson holds Origin Sciences share options. Author IR Daniels holds Origin Sciences share options and is a paid consultant to Origin Sciences. Author B Nedjai holds Origin Sciences share options and is a paid consultant to Origin Sciences. ET Walker is a surgical research fellow funded by an unrestricted research grant from Origin Sciences. H Sisodia is a surgical research fellow funded by an unrestricted research grant from Origin Sciences. H Rottenberg is a surgical research fellow funded by an unrestricted research grant from Origin Sciences. S Bird is a research nurse funded by an unrestricted research grant from Origin Sciences. GAR Jones is a surgical research fellow funded by an unrestricted research grant from Origin Sciences. D Wise is employed by Origin Sciences. SJ Spencer holds Origin Sciences share options and is contracted to Origin Sciences as Clinical Study Manager.FD McDermott has no financial disclosures relevant to this study. NJ Battersby has no financial disclosures relevant to this study. C Cunningham has no financial disclosures relevant to this study.
: All procedures performed the ORI-EGI-02 study involving human participants were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Health Research Authority/National Research Ethics Service/ East Midlands-Nottingham 1 Research Ethics Committee (REC Reference: 19/EM/0266). The study was completed in accordance with STROBE guidelines.
: Health Research Authority/National Research Ethics Service/East Midlands-Nottingham 1 Research Ethics Committee. <i>REC reference:</i> 19/EM/0266; <i>Protocol number:</i> Ori-EGI-02; <i>IRAS project ID:</i> 263745; <i>ClinicalTrials.gov:</i> NCT04659590.
: Written informed consent was obtained from all individual participants included in the study.
: Written informed consent obtained from all individual participants included a signed statement regarding permission to publish.
Free to read: This content has been made available to all.